Global Varicose Veins Treatment Market is anticipated to witness the growth of steady CAGR in the forecast period, 2024-2028. It can be ascribed to the rising advanced varicose vein treatment devices escalating the market growth. Besides, surging preference for minimally invasive treatment procedures is expected to drive the growth of global varicose vein treatment market. Additionally, the availability of advanced varicose vein treatment devices is further expected to support the market growth. Moreover, rise in the technological advancements and modernization in the healthcare devices, rise in the research and development activities in the healthcare sector will further create new opportunities for the varicose vein treatment market in the forecasted period. On the contrary, growing R&D and rise in awareness among healthcare professionals as well as patients regarding varicose vein treatment are expected to create lucrative opportunities in future. Chronic Venous Insufficiency (CVI) commonly affects lower limbs with a prevalence ranging between 25–40% and 10–20% in women and men, respectively. The annual incidence is 2–6% in women and 1.9% in men. Moreover, advances in medical technology have led to the development of more effective and minimally invasive treatment options. These treatments, which include endovenous laser treatment (EVLT), radiofrequency ablation (RFA), and sclerotherapy, are becoming increasingly popular among patients due to their effectiveness, safety, and minimal downtime. Another factor contributing to the growth of the varicose veins treatment market is the increasing awareness about the condition and found at treatment options. Healthcare professionals and organizations are actively promoting the importance of early detection and treatment of varicose veins, which is driving patient demand for these treatments. Compression stockings are specially designed stockings that apply pressure to the legs, helping to improve blood flow and prevent the pooling of blood in the veins. These stockings are often the first line of treatment for varicose veins and are found at in different strengths and styles. Phlebotonics are medicines that improve the tone and elasticity of the veins, reducing inflammation and pain. They are often used in combination with other treatments. Anticoagulants are medicines that help to prevent blood clots from forming in the veins, reducing the risk of complications such as deep vein thrombosis. There is a lack of awareness among the general population about the symptoms, causes, and treatment options for varicose veins. This results in many people delaying seeking medical attention or not receiving proper treatment, which can lead to complications and the worsening of the condition. The cost of varicose veins treatment can be high, particularly in developed countries where healthcare costs are generally higher. This can make it difficult for some patients to access treatment, particularly if they are uninsured or underinsured. There are several alternative treatments found at for varicose veins, including home remedies, herbal remedies, and traditional medicine. These alternative treatments may be less effective than traditional medical treatments, but they can be more affordable and accessible to some patients.
Rising Prevalence of Venous Disorders
It is estimated that 41% of women over the age of 50 have varicose veins. It is estimated that 50% of the US population over 50 years old has varicose veins. Women who are moderately overweight (BMI 25-29.9) have a 50% increased risk of developing varicose veins compared to women who are not overweight.
Technological Advancements
The global market is likely to be driven by continuous advancements in varicose veins treatment devices and an increase in the incidence of varicose veins illness. The use of a compression device to treat varicose veins has grown in popularity because it improves blood circulation by applying mild pressure. In addition, various advantages of Laser treatment, such as painless 30 minutes procedure, minimal risk of reoccurrence, minimum invasion, quick recovery, etc., are predicted to help the growth of the Varicose Veins Treatment Market over the projection year. According to the Occupational Safety and Health Research Institute, the prevalence of lower limb varicose veins varies between 10% and 30% globally. Furthermore, in the forecasted period, technical improvements and modernization in healthcare devices increased research and development efforts in the healthcare sector. Increased growth in emerging regions will generate lucrative growth opportunities for the Varicose Veins Treatment Market shortly. The development of new and innovative treatment options, such as endovenous laser treatment (EVLT), radiofrequency ablation (RFA), and sclerotherapy, has revolutionized the treatment of varicose veins. These minimally invasive treatment options offer several advantages over traditional surgical methods, such as reduced recovery time and minimal scarring. Technological advancements in imaging and diagnostics have enabled healthcare professionals to diagnose and treat varicose veins more accurately and efficiently. This has led to an increase in the success rates of varicose veins treatments and a higher level of patient satisfaction. One of the most significant developments in the treatment of varicose veins is the increased use of endovenous thermal ablation techniques. These techniques involve the use of heat energy to close off damaged veins, and they are less invasive than traditional surgical methods. In recent years, several new endovenous thermal ablation techniques have been launched, including steam vein sclerosis, which uses steam to close off damaged veins. Another new treatment option for varicose veins is cyanoacrylate glue closure. This technique involves the use of medical-grade glue to close off damaged veins, and it has been found to be both safe and effective. One example of a recent advancement in varicose veins treatment is the use of VenaSeal, a medical adhesive that is used to close off damaged veins. VenaSeal has been shown to be safe and effective in clinical studies and is less invasive than traditional surgical methods. Another recent development is the use of radiofrequency ablation (RFA) and laser ablation techniques. RFA and laser ablation use heat energy to close off damaged veins, and they are less invasive than traditional surgical methods. These techniques have been found to be both safe and effective and offer patients a quicker recovery time.
Recent Development
- HERACLION (ISINFR0010120402; Mnemo ALTHE, PEA-PME eligible) (ParisALTHE), an innovative company specialized in echotherapy treatment (using High Intensity Focused Ultrasound or HIFU), has obtained CE Mark for the second generation of SONOVEIN®, it’s HIFU treatment solution for varicose veins. It has also signed a strategic supplier partnership with SuperSonic Imaging (part of Hologic Inc.). Theraclion’s ambition is to give all patients access to non-invasive varicose vein treatments.
Market Segmentation
In terms of country, among United States, North American region is dominating the overall globe in the varicose vein treatment market. Approximately 23% of US adults have varicose veins. If spider telangiectasias and reticular veins are also considered, the prevalence increases to 80% of men and 85% of women.
Market Players
Alma Lasers Limited, Medtronic Plc., Boston Scientific Corporation (Lumenis Corporation), Sciton, Inc., Merit Medical Systems, Inc., BTG International Limited, Energist Limited, Teleflex Incorporated, AngioDynamics, Inc., El. En SpA Group (Quanta System), are some of the leading players operating in the Global Varicose Veins Treatment Market.
Attribute | Details |
Base Year | 2022 |
Historic Data | 2018 – 2021 |
Estimated Year | 2023 |
Forecast Period | 2024 – 2028 |
Quantitative Units | Revenue in USD Million, and CAGR for 2018-2022 and 2023-2028 |
Report coverage | Revenue forecast, volume forecast, company share, competitive landscape, growth factors, and trends |
Segments covered | · By Type · By Component · By End User · By Region |
Regional scope | North America; Europe; Asia Pacific; South America; Middle East & Africa |
Country scope | United States; Mexico; Canada; France; Germany; United Kingdom; Italy; Spain; China; India; Japan; South Korea; Australia; Brazil; Argentina; Colombia; South Africa; Saudi Arabia; UAE |
Key companies profiled | Alma Lasers Limited, Medtronic Plc., Boston Scientific Corporation (Lumenis Corporation), Sciton, Inc, Merit Medical Systems, Inc., BTG International Limited, Energist Limited, Teleflex Incorporated, AngioDynamics, Inc., El. En SpA Group (Quanta System) |
Customization scope | 10% free report customization with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options | Avail customized purchase options to meet your exact research needs. Explore purchase options |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |